Global Dry Age-Related Macular Degeneration Market Research Report 2026(Status and Outlook)
Dry macular degeneration is a common eye disorder among people over 50. It causes blurred or reduced central vision, due to thinning of the macula (MAK-u-luh). The macula is the part of the retina responsible for clear vision in your direct line of sight.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Dry Age-Related Macular Degeneration market size was estimated at USD 1558.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Dry Age-Related Macular Degeneration market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Dry Age-Related Macular Degeneration market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Dry Age-Related Macular Degeneration market.
Global Dry Age-Related Macular Degeneration Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Santen Pharmaceuticals
Allergan
Bausch Health
Alimera Science
Phio Pharmaceuticals
Ocumension Therapeutics
Belite Bio
Kubota Vision
Iveric Bio
Eyestem Research
Y2 Solution
Stealth Biotherapeutics
Market Segmentation (by Type)
Oral
Injectables
Market Segmentation (by Application)
Above 40 Years
Above 60 Years
Above 75 Years
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Dry Age-Related Macular Degeneration Market
Overview of the regional outlook of the Dry Age-Related Macular Degeneration Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Dry Age-Related Macular Degeneration Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Dry Age-Related Macular Degeneration, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Dry Age-Related Macular Degeneration market size was estimated at USD 1558.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Dry Age-Related Macular Degeneration market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Dry Age-Related Macular Degeneration market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Dry Age-Related Macular Degeneration market.
Global Dry Age-Related Macular Degeneration Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Santen Pharmaceuticals
Allergan
Bausch Health
Alimera Science
Phio Pharmaceuticals
Ocumension Therapeutics
Belite Bio
Kubota Vision
Iveric Bio
Eyestem Research
Y2 Solution
Stealth Biotherapeutics
Market Segmentation (by Type)
Oral
Injectables
Market Segmentation (by Application)
Above 40 Years
Above 60 Years
Above 75 Years
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Dry Age-Related Macular Degeneration Market
Overview of the regional outlook of the Dry Age-Related Macular Degeneration Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Dry Age-Related Macular Degeneration Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Dry Age-Related Macular Degeneration, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Dry Age-Related Macular Degeneration
1.2 Key Market Segments
1.2.1 Dry Age-Related Macular Degeneration Segment by Type
1.2.2 Dry Age-Related Macular Degeneration Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DRY AGE-RELATED MACULAR DEGENERATION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Dry Age-Related Macular Degeneration Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Dry Age-Related Macular Degeneration Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DRY AGE-RELATED MACULAR DEGENERATION MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Dry Age-Related Macular Degeneration Product Life Cycle
3.3 Global Dry Age-Related Macular Degeneration Sales by Manufacturers (2020-2025)
3.4 Global Dry Age-Related Macular Degeneration Revenue Market Share by Manufacturers (2020-2025)
3.5 Dry Age-Related Macular Degeneration Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Dry Age-Related Macular Degeneration Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Dry Age-Related Macular Degeneration Market Competitive Situation and Trends
3.8.1 Dry Age-Related Macular Degeneration Market Concentration Rate
3.8.2 Global 5 and 10 Largest Dry Age-Related Macular Degeneration Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 DRY AGE-RELATED MACULAR DEGENERATION INDUSTRY CHAIN ANALYSIS
4.1 Dry Age-Related Macular Degeneration Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DRY AGE-RELATED MACULAR DEGENERATION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Dry Age-Related Macular Degeneration Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Dry Age-Related Macular Degeneration Market
5.7 ESG Ratings of Leading Companies
6 DRY AGE-RELATED MACULAR DEGENERATION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Dry Age-Related Macular Degeneration Sales Market Share by Type (2020-2025)
6.3 Global Dry Age-Related Macular Degeneration Market Size by Type (2020-2025)
6.4 Global Dry Age-Related Macular Degeneration Price by Type (2020-2025)
7 DRY AGE-RELATED MACULAR DEGENERATION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Dry Age-Related Macular Degeneration Market Sales by Application (2020-2025)
7.3 Global Dry Age-Related Macular Degeneration Market Size (M USD) by Application (2020-2025)
7.4 Global Dry Age-Related Macular Degeneration Sales Growth Rate by Application (2020-2025)
8 DRY AGE-RELATED MACULAR DEGENERATION MARKET SALES BY REGION
8.1 Global Dry Age-Related Macular Degeneration Sales by Region
8.1.1 Global Dry Age-Related Macular Degeneration Sales by Region
8.1.2 Global Dry Age-Related Macular Degeneration Sales Market Share by Region
8.2 Global Dry Age-Related Macular Degeneration Market Size by Region
8.2.1 Global Dry Age-Related Macular Degeneration Market Size by Region
8.2.2 Global Dry Age-Related Macular Degeneration Market Size by Region
8.3 North America
8.3.1 North America Dry Age-Related Macular Degeneration Sales by Country
8.3.2 North America Dry Age-Related Macular Degeneration Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Dry Age-Related Macular Degeneration Sales by Country
8.4.2 Europe Dry Age-Related Macular Degeneration Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Dry Age-Related Macular Degeneration Sales by Region
8.5.2 Asia Pacific Dry Age-Related Macular Degeneration Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Dry Age-Related Macular Degeneration Sales by Country
8.6.2 South America Dry Age-Related Macular Degeneration Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Dry Age-Related Macular Degeneration Sales by Region
8.7.2 Middle East and Africa Dry Age-Related Macular Degeneration Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 DRY AGE-RELATED MACULAR DEGENERATION MARKET PRODUCTION BY REGION
9.1 Global Production of Dry Age-Related Macular Degeneration by Region(2020-2025)
9.2 Global Dry Age-Related Macular Degeneration Revenue Market Share by Region (2020-2025)
9.3 Global Dry Age-Related Macular Degeneration Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Dry Age-Related Macular Degeneration Production
9.4.1 North America Dry Age-Related Macular Degeneration Production Growth Rate (2020-2025)
9.4.2 North America Dry Age-Related Macular Degeneration Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Dry Age-Related Macular Degeneration Production
9.5.1 Europe Dry Age-Related Macular Degeneration Production Growth Rate (2020-2025)
9.5.2 Europe Dry Age-Related Macular Degeneration Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Dry Age-Related Macular Degeneration Production (2020-2025)
9.6.1 Japan Dry Age-Related Macular Degeneration Production Growth Rate (2020-2025)
9.6.2 Japan Dry Age-Related Macular Degeneration Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Dry Age-Related Macular Degeneration Production (2020-2025)
9.7.1 China Dry Age-Related Macular Degeneration Production Growth Rate (2020-2025)
9.7.2 China Dry Age-Related Macular Degeneration Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Santen Pharmaceuticals
10.1.1 Santen Pharmaceuticals Basic Information
10.1.2 Santen Pharmaceuticals Dry Age-Related Macular Degeneration Product Overview
10.1.3 Santen Pharmaceuticals Dry Age-Related Macular Degeneration Product Market Performance
10.1.4 Santen Pharmaceuticals Business Overview
10.1.5 Santen Pharmaceuticals SWOT Analysis
10.1.6 Santen Pharmaceuticals Recent Developments
10.2 Allergan
10.2.1 Allergan Basic Information
10.2.2 Allergan Dry Age-Related Macular Degeneration Product Overview
10.2.3 Allergan Dry Age-Related Macular Degeneration Product Market Performance
10.2.4 Allergan Business Overview
10.2.5 Allergan SWOT Analysis
10.2.6 Allergan Recent Developments
10.3 Bausch Health
10.3.1 Bausch Health Basic Information
10.3.2 Bausch Health Dry Age-Related Macular Degeneration Product Overview
10.3.3 Bausch Health Dry Age-Related Macular Degeneration Product Market Performance
10.3.4 Bausch Health Business Overview
10.3.5 Bausch Health SWOT Analysis
10.3.6 Bausch Health Recent Developments
10.4 Alimera Science
10.4.1 Alimera Science Basic Information
10.4.2 Alimera Science Dry Age-Related Macular Degeneration Product Overview
10.4.3 Alimera Science Dry Age-Related Macular Degeneration Product Market Performance
10.4.4 Alimera Science Business Overview
10.4.5 Alimera Science Recent Developments
10.5 Phio Pharmaceuticals
10.5.1 Phio Pharmaceuticals Basic Information
10.5.2 Phio Pharmaceuticals Dry Age-Related Macular Degeneration Product Overview
10.5.3 Phio Pharmaceuticals Dry Age-Related Macular Degeneration Product Market Performance
10.5.4 Phio Pharmaceuticals Business Overview
10.5.5 Phio Pharmaceuticals Recent Developments
10.6 Ocumension Therapeutics
10.6.1 Ocumension Therapeutics Basic Information
10.6.2 Ocumension Therapeutics Dry Age-Related Macular Degeneration Product Overview
10.6.3 Ocumension Therapeutics Dry Age-Related Macular Degeneration Product Market Performance
10.6.4 Ocumension Therapeutics Business Overview
10.6.5 Ocumension Therapeutics Recent Developments
10.7 Belite Bio
10.7.1 Belite Bio Basic Information
10.7.2 Belite Bio Dry Age-Related Macular Degeneration Product Overview
10.7.3 Belite Bio Dry Age-Related Macular Degeneration Product Market Performance
10.7.4 Belite Bio Business Overview
10.7.5 Belite Bio Recent Developments
10.8 Kubota Vision
10.8.1 Kubota Vision Basic Information
10.8.2 Kubota Vision Dry Age-Related Macular Degeneration Product Overview
10.8.3 Kubota Vision Dry Age-Related Macular Degeneration Product Market Performance
10.8.4 Kubota Vision Business Overview
10.8.5 Kubota Vision Recent Developments
10.9 Iveric Bio
10.9.1 Iveric Bio Basic Information
10.9.2 Iveric Bio Dry Age-Related Macular Degeneration Product Overview
10.9.3 Iveric Bio Dry Age-Related Macular Degeneration Product Market Performance
10.9.4 Iveric Bio Business Overview
10.9.5 Iveric Bio Recent Developments
10.10 Eyestem Research
10.10.1 Eyestem Research Basic Information
10.10.2 Eyestem Research Dry Age-Related Macular Degeneration Product Overview
10.10.3 Eyestem Research Dry Age-Related Macular Degeneration Product Market Performance
10.10.4 Eyestem Research Business Overview
10.10.5 Eyestem Research Recent Developments
10.11 Y2 Solution
10.11.1 Y2 Solution Basic Information
10.11.2 Y2 Solution Dry Age-Related Macular Degeneration Product Overview
10.11.3 Y2 Solution Dry Age-Related Macular Degeneration Product Market Performance
10.11.4 Y2 Solution Business Overview
10.11.5 Y2 Solution Recent Developments
10.12 Stealth Biotherapeutics
10.12.1 Stealth Biotherapeutics Basic Information
10.12.2 Stealth Biotherapeutics Dry Age-Related Macular Degeneration Product Overview
10.12.3 Stealth Biotherapeutics Dry Age-Related Macular Degeneration Product Market Performance
10.12.4 Stealth Biotherapeutics Business Overview
10.12.5 Stealth Biotherapeutics Recent Developments
11 DRY AGE-RELATED MACULAR DEGENERATION MARKET FORECAST BY REGION
11.1 Global Dry Age-Related Macular Degeneration Market Size Forecast
11.2 Global Dry Age-Related Macular Degeneration Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Dry Age-Related Macular Degeneration Market Size Forecast by Country
11.2.3 Asia Pacific Dry Age-Related Macular Degeneration Market Size Forecast by Region
11.2.4 South America Dry Age-Related Macular Degeneration Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Dry Age-Related Macular Degeneration by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Dry Age-Related Macular Degeneration Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Dry Age-Related Macular Degeneration by Type (2026-2035)
12.1.2 Global Dry Age-Related Macular Degeneration Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Dry Age-Related Macular Degeneration by Type (2026-2035)
12.2 Global Dry Age-Related Macular Degeneration Market Forecast by Application (2026-2035)
12.2.1 Global Dry Age-Related Macular Degeneration Sales (K MT) Forecast by Application
12.2.2 Global Dry Age-Related Macular Degeneration Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Dry Age-Related Macular Degeneration
1.2 Key Market Segments
1.2.1 Dry Age-Related Macular Degeneration Segment by Type
1.2.2 Dry Age-Related Macular Degeneration Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DRY AGE-RELATED MACULAR DEGENERATION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Dry Age-Related Macular Degeneration Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Dry Age-Related Macular Degeneration Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DRY AGE-RELATED MACULAR DEGENERATION MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Dry Age-Related Macular Degeneration Product Life Cycle
3.3 Global Dry Age-Related Macular Degeneration Sales by Manufacturers (2020-2025)
3.4 Global Dry Age-Related Macular Degeneration Revenue Market Share by Manufacturers (2020-2025)
3.5 Dry Age-Related Macular Degeneration Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Dry Age-Related Macular Degeneration Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Dry Age-Related Macular Degeneration Market Competitive Situation and Trends
3.8.1 Dry Age-Related Macular Degeneration Market Concentration Rate
3.8.2 Global 5 and 10 Largest Dry Age-Related Macular Degeneration Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 DRY AGE-RELATED MACULAR DEGENERATION INDUSTRY CHAIN ANALYSIS
4.1 Dry Age-Related Macular Degeneration Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DRY AGE-RELATED MACULAR DEGENERATION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Dry Age-Related Macular Degeneration Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Dry Age-Related Macular Degeneration Market
5.7 ESG Ratings of Leading Companies
6 DRY AGE-RELATED MACULAR DEGENERATION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Dry Age-Related Macular Degeneration Sales Market Share by Type (2020-2025)
6.3 Global Dry Age-Related Macular Degeneration Market Size by Type (2020-2025)
6.4 Global Dry Age-Related Macular Degeneration Price by Type (2020-2025)
7 DRY AGE-RELATED MACULAR DEGENERATION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Dry Age-Related Macular Degeneration Market Sales by Application (2020-2025)
7.3 Global Dry Age-Related Macular Degeneration Market Size (M USD) by Application (2020-2025)
7.4 Global Dry Age-Related Macular Degeneration Sales Growth Rate by Application (2020-2025)
8 DRY AGE-RELATED MACULAR DEGENERATION MARKET SALES BY REGION
8.1 Global Dry Age-Related Macular Degeneration Sales by Region
8.1.1 Global Dry Age-Related Macular Degeneration Sales by Region
8.1.2 Global Dry Age-Related Macular Degeneration Sales Market Share by Region
8.2 Global Dry Age-Related Macular Degeneration Market Size by Region
8.2.1 Global Dry Age-Related Macular Degeneration Market Size by Region
8.2.2 Global Dry Age-Related Macular Degeneration Market Size by Region
8.3 North America
8.3.1 North America Dry Age-Related Macular Degeneration Sales by Country
8.3.2 North America Dry Age-Related Macular Degeneration Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Dry Age-Related Macular Degeneration Sales by Country
8.4.2 Europe Dry Age-Related Macular Degeneration Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Dry Age-Related Macular Degeneration Sales by Region
8.5.2 Asia Pacific Dry Age-Related Macular Degeneration Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Dry Age-Related Macular Degeneration Sales by Country
8.6.2 South America Dry Age-Related Macular Degeneration Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Dry Age-Related Macular Degeneration Sales by Region
8.7.2 Middle East and Africa Dry Age-Related Macular Degeneration Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 DRY AGE-RELATED MACULAR DEGENERATION MARKET PRODUCTION BY REGION
9.1 Global Production of Dry Age-Related Macular Degeneration by Region(2020-2025)
9.2 Global Dry Age-Related Macular Degeneration Revenue Market Share by Region (2020-2025)
9.3 Global Dry Age-Related Macular Degeneration Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Dry Age-Related Macular Degeneration Production
9.4.1 North America Dry Age-Related Macular Degeneration Production Growth Rate (2020-2025)
9.4.2 North America Dry Age-Related Macular Degeneration Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Dry Age-Related Macular Degeneration Production
9.5.1 Europe Dry Age-Related Macular Degeneration Production Growth Rate (2020-2025)
9.5.2 Europe Dry Age-Related Macular Degeneration Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Dry Age-Related Macular Degeneration Production (2020-2025)
9.6.1 Japan Dry Age-Related Macular Degeneration Production Growth Rate (2020-2025)
9.6.2 Japan Dry Age-Related Macular Degeneration Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Dry Age-Related Macular Degeneration Production (2020-2025)
9.7.1 China Dry Age-Related Macular Degeneration Production Growth Rate (2020-2025)
9.7.2 China Dry Age-Related Macular Degeneration Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Santen Pharmaceuticals
10.1.1 Santen Pharmaceuticals Basic Information
10.1.2 Santen Pharmaceuticals Dry Age-Related Macular Degeneration Product Overview
10.1.3 Santen Pharmaceuticals Dry Age-Related Macular Degeneration Product Market Performance
10.1.4 Santen Pharmaceuticals Business Overview
10.1.5 Santen Pharmaceuticals SWOT Analysis
10.1.6 Santen Pharmaceuticals Recent Developments
10.2 Allergan
10.2.1 Allergan Basic Information
10.2.2 Allergan Dry Age-Related Macular Degeneration Product Overview
10.2.3 Allergan Dry Age-Related Macular Degeneration Product Market Performance
10.2.4 Allergan Business Overview
10.2.5 Allergan SWOT Analysis
10.2.6 Allergan Recent Developments
10.3 Bausch Health
10.3.1 Bausch Health Basic Information
10.3.2 Bausch Health Dry Age-Related Macular Degeneration Product Overview
10.3.3 Bausch Health Dry Age-Related Macular Degeneration Product Market Performance
10.3.4 Bausch Health Business Overview
10.3.5 Bausch Health SWOT Analysis
10.3.6 Bausch Health Recent Developments
10.4 Alimera Science
10.4.1 Alimera Science Basic Information
10.4.2 Alimera Science Dry Age-Related Macular Degeneration Product Overview
10.4.3 Alimera Science Dry Age-Related Macular Degeneration Product Market Performance
10.4.4 Alimera Science Business Overview
10.4.5 Alimera Science Recent Developments
10.5 Phio Pharmaceuticals
10.5.1 Phio Pharmaceuticals Basic Information
10.5.2 Phio Pharmaceuticals Dry Age-Related Macular Degeneration Product Overview
10.5.3 Phio Pharmaceuticals Dry Age-Related Macular Degeneration Product Market Performance
10.5.4 Phio Pharmaceuticals Business Overview
10.5.5 Phio Pharmaceuticals Recent Developments
10.6 Ocumension Therapeutics
10.6.1 Ocumension Therapeutics Basic Information
10.6.2 Ocumension Therapeutics Dry Age-Related Macular Degeneration Product Overview
10.6.3 Ocumension Therapeutics Dry Age-Related Macular Degeneration Product Market Performance
10.6.4 Ocumension Therapeutics Business Overview
10.6.5 Ocumension Therapeutics Recent Developments
10.7 Belite Bio
10.7.1 Belite Bio Basic Information
10.7.2 Belite Bio Dry Age-Related Macular Degeneration Product Overview
10.7.3 Belite Bio Dry Age-Related Macular Degeneration Product Market Performance
10.7.4 Belite Bio Business Overview
10.7.5 Belite Bio Recent Developments
10.8 Kubota Vision
10.8.1 Kubota Vision Basic Information
10.8.2 Kubota Vision Dry Age-Related Macular Degeneration Product Overview
10.8.3 Kubota Vision Dry Age-Related Macular Degeneration Product Market Performance
10.8.4 Kubota Vision Business Overview
10.8.5 Kubota Vision Recent Developments
10.9 Iveric Bio
10.9.1 Iveric Bio Basic Information
10.9.2 Iveric Bio Dry Age-Related Macular Degeneration Product Overview
10.9.3 Iveric Bio Dry Age-Related Macular Degeneration Product Market Performance
10.9.4 Iveric Bio Business Overview
10.9.5 Iveric Bio Recent Developments
10.10 Eyestem Research
10.10.1 Eyestem Research Basic Information
10.10.2 Eyestem Research Dry Age-Related Macular Degeneration Product Overview
10.10.3 Eyestem Research Dry Age-Related Macular Degeneration Product Market Performance
10.10.4 Eyestem Research Business Overview
10.10.5 Eyestem Research Recent Developments
10.11 Y2 Solution
10.11.1 Y2 Solution Basic Information
10.11.2 Y2 Solution Dry Age-Related Macular Degeneration Product Overview
10.11.3 Y2 Solution Dry Age-Related Macular Degeneration Product Market Performance
10.11.4 Y2 Solution Business Overview
10.11.5 Y2 Solution Recent Developments
10.12 Stealth Biotherapeutics
10.12.1 Stealth Biotherapeutics Basic Information
10.12.2 Stealth Biotherapeutics Dry Age-Related Macular Degeneration Product Overview
10.12.3 Stealth Biotherapeutics Dry Age-Related Macular Degeneration Product Market Performance
10.12.4 Stealth Biotherapeutics Business Overview
10.12.5 Stealth Biotherapeutics Recent Developments
11 DRY AGE-RELATED MACULAR DEGENERATION MARKET FORECAST BY REGION
11.1 Global Dry Age-Related Macular Degeneration Market Size Forecast
11.2 Global Dry Age-Related Macular Degeneration Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Dry Age-Related Macular Degeneration Market Size Forecast by Country
11.2.3 Asia Pacific Dry Age-Related Macular Degeneration Market Size Forecast by Region
11.2.4 South America Dry Age-Related Macular Degeneration Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Dry Age-Related Macular Degeneration by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Dry Age-Related Macular Degeneration Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Dry Age-Related Macular Degeneration by Type (2026-2035)
12.1.2 Global Dry Age-Related Macular Degeneration Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Dry Age-Related Macular Degeneration by Type (2026-2035)
12.2 Global Dry Age-Related Macular Degeneration Market Forecast by Application (2026-2035)
12.2.1 Global Dry Age-Related Macular Degeneration Sales (K MT) Forecast by Application
12.2.2 Global Dry Age-Related Macular Degeneration Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Dry Age-Related Macular Degeneration Market Size by Type (M USD)
Table 4. Global Dry Age-Related Macular Degeneration Market Size by Application
Table 5. Dry Age-Related Macular Degeneration Market Size Comparison by Region (M USD)
Table 6. Global Dry Age-Related Macular Degeneration Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Dry Age-Related Macular Degeneration Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Dry Age-Related Macular Degeneration Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Dry Age-Related Macular Degeneration Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Age-Related Macular Degeneration as of 2025)
Table 11. Global Market Dry Age-Related Macular Degeneration Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Dry Age-Related Macular Degeneration Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Dry Age-Related Macular Degeneration Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Dry Age-Related Macular Degeneration Sales by Type (K MT)
Table 27. Global Dry Age-Related Macular Degeneration Market Size by Type (M USD)
Table 28. Global Dry Age-Related Macular Degeneration Sales (K MT) by Type (2020-2025)
Table 29. Global Dry Age-Related Macular Degeneration Sales Market Share by Type (2020-2025)
Table 30. Global Dry Age-Related Macular Degeneration Market Size (M USD) by Type (2020-2025)
Table 31. Global Dry Age-Related Macular Degeneration Market Share by Type (2020-2025)
Table 32. Global Dry Age-Related Macular Degeneration Price (USD/KG) by Type (2020-2025)
Table 33. Global Dry Age-Related Macular Degeneration Sales (K MT) by Application
Table 34. Global Dry Age-Related Macular Degeneration Market Size by Application
Table 35. Global Dry Age-Related Macular Degeneration Sales by Application (2020-2025) & (K MT)
Table 36. Global Dry Age-Related Macular Degeneration Sales Market Share by Application (2020-2025)
Table 37. Global Dry Age-Related Macular Degeneration Market Size by Application (2020-2025) & (M USD)
Table 38. Global Dry Age-Related Macular Degeneration Market Share by Application (2020-2025)
Table 39. Global Dry Age-Related Macular Degeneration Sales Growth Rate by Application (2020-2025)
Table 40. Global Dry Age-Related Macular Degeneration Sales by Region (2020-2025) & (K MT)
Table 41. Global Dry Age-Related Macular Degeneration Sales Market Share by Region (2020-2025)
Table 42. Global Dry Age-Related Macular Degeneration Market Size by Region (2020-2025) & (M USD)
Table 43. Global Dry Age-Related Macular Degeneration Market Size by Region (2020-2025)
Table 44. North America Dry Age-Related Macular Degeneration Sales by Country (2020-2025) & (K MT)
Table 45. North America Dry Age-Related Macular Degeneration Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Dry Age-Related Macular Degeneration Sales by Country (2020-2025) & (K MT)
Table 47. Europe Dry Age-Related Macular Degeneration Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Dry Age-Related Macular Degeneration Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Dry Age-Related Macular Degeneration Market Size by Region (2020-2025) & (M USD)
Table 50. South America Dry Age-Related Macular Degeneration Sales by Country (2020-2025) & (K MT)
Table 51. South America Dry Age-Related Macular Degeneration Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Dry Age-Related Macular Degeneration Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Dry Age-Related Macular Degeneration Market Size by Region (2020-2025) & (M USD)
Table 54. Global Dry Age-Related Macular Degeneration Production (K MT) by Region(2020-2025)
Table 55. Global Dry Age-Related Macular Degeneration Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Dry Age-Related Macular Degeneration Revenue Market Share by Region (2020-2025)
Table 57. Global Dry Age-Related Macular Degeneration Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Dry Age-Related Macular Degeneration Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Dry Age-Related Macular Degeneration Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Dry Age-Related Macular Degeneration Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Dry Age-Related Macular Degeneration Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Santen Pharmaceuticals Basic Information
Table 63. Santen Pharmaceuticals Dry Age-Related Macular Degeneration Product Overview
Table 64. Santen Pharmaceuticals Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Santen Pharmaceuticals Business Overview
Table 66. Santen Pharmaceuticals SWOT Analysis
Table 67. Santen Pharmaceuticals Recent Developments
Table 68. Allergan Basic Information
Table 69. Allergan Dry Age-Related Macular Degeneration Product Overview
Table 70. Allergan Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Allergan Business Overview
Table 72. Allergan SWOT Analysis
Table 73. Allergan Recent Developments
Table 74. Bausch Health Basic Information
Table 75. Bausch Health Dry Age-Related Macular Degeneration Product Overview
Table 76. Bausch Health Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Bausch Health Business Overview
Table 78. Bausch Health SWOT Analysis
Table 79. Bausch Health Recent Developments
Table 80. Alimera Science Basic Information
Table 81. Alimera Science Dry Age-Related Macular Degeneration Product Overview
Table 82. Alimera Science Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Alimera Science Business Overview
Table 84. Alimera Science Recent Developments
Table 85. Phio Pharmaceuticals Basic Information
Table 86. Phio Pharmaceuticals Dry Age-Related Macular Degeneration Product Overview
Table 87. Phio Pharmaceuticals Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Phio Pharmaceuticals Business Overview
Table 89. Phio Pharmaceuticals Recent Developments
Table 90. Ocumension Therapeutics Basic Information
Table 91. Ocumension Therapeutics Dry Age-Related Macular Degeneration Product Overview
Table 92. Ocumension Therapeutics Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Ocumension Therapeutics Business Overview
Table 94. Ocumension Therapeutics Recent Developments
Table 95. Belite Bio Basic Information
Table 96. Belite Bio Dry Age-Related Macular Degeneration Product Overview
Table 97. Belite Bio Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Belite Bio Business Overview
Table 99. Belite Bio Recent Developments
Table 100. Kubota Vision Basic Information
Table 101. Kubota Vision Dry Age-Related Macular Degeneration Product Overview
Table 102. Kubota Vision Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Kubota Vision Business Overview
Table 104. Kubota Vision Recent Developments
Table 105. Iveric Bio Basic Information
Table 106. Iveric Bio Dry Age-Related Macular Degeneration Product Overview
Table 107. Iveric Bio Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Iveric Bio Business Overview
Table 109. Iveric Bio Recent Developments
Table 110. Eyestem Research Basic Information
Table 111. Eyestem Research Dry Age-Related Macular Degeneration Product Overview
Table 112. Eyestem Research Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Eyestem Research Business Overview
Table 114. Eyestem Research Recent Developments
Table 115. Y2 Solution Basic Information
Table 116. Y2 Solution Dry Age-Related Macular Degeneration Product Overview
Table 117. Y2 Solution Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Y2 Solution Business Overview
Table 119. Y2 Solution Recent Developments
Table 120. Stealth Biotherapeutics Basic Information
Table 121. Stealth Biotherapeutics Dry Age-Related Macular Degeneration Product Overview
Table 122. Stealth Biotherapeutics Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Stealth Biotherapeutics Business Overview
Table 124. Stealth Biotherapeutics Recent Developments
Table 125. Global Dry Age-Related Macular Degeneration Sales Forecast by Region (2026-2035) & (K MT)
Table 126. Global Dry Age-Related Macular Degeneration Market Size Forecast by Region (2026-2035) & (M USD)
Table 127. North America Dry Age-Related Macular Degeneration Sales Forecast by Country (2026-2035) & (K MT)
Table 128. North America Dry Age-Related Macular Degeneration Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Europe Dry Age-Related Macular Degeneration Sales Forecast by Country (2026-2035) & (K MT)
Table 130. Europe Dry Age-Related Macular Degeneration Market Size Forecast by Country (2026-2035) & (M USD)
Table 131. Asia Pacific Dry Age-Related Macular Degeneration Sales Forecast by Region (2026-2035) & (K MT)
Table 132. Asia Pacific Dry Age-Related Macular Degeneration Market Size Forecast by Region (2026-2035) & (M USD)
Table 133. South America Dry Age-Related Macular Degeneration Sales Forecast by Country (2026-2035) & (K MT)
Table 134. South America Dry Age-Related Macular Degeneration Market Size Forecast by Country (2026-2035) & (M USD)
Table 135. Middle East and Africa Dry Age-Related Macular Degeneration Sales Forecast by Country (2026-2035) & (Units)
Table 136. Middle East and Africa Dry Age-Related Macular Degeneration Market Size Forecast by Country (2026-2035) & (M USD)
Table 137. Global Dry Age-Related Macular Degeneration Sales Forecast by Type (2026-2035) & (K MT)
Table 138. Global Dry Age-Related Macular Degeneration Market Size Forecast by Type (2026-2035) & (M USD)
Table 139. Global Dry Age-Related Macular Degeneration Price Forecast by Type (2026-2035) & (USD/KG)
Table 140. Global Dry Age-Related Macular Degeneration Sales (K MT) Forecast by Application (2026-2035)
Table 141. Global Dry Age-Related Macular Degeneration Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Dry Age-Related Macular Degeneration Market Size by Type (M USD)
Table 4. Global Dry Age-Related Macular Degeneration Market Size by Application
Table 5. Dry Age-Related Macular Degeneration Market Size Comparison by Region (M USD)
Table 6. Global Dry Age-Related Macular Degeneration Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Dry Age-Related Macular Degeneration Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Dry Age-Related Macular Degeneration Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Dry Age-Related Macular Degeneration Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Age-Related Macular Degeneration as of 2025)
Table 11. Global Market Dry Age-Related Macular Degeneration Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Dry Age-Related Macular Degeneration Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Dry Age-Related Macular Degeneration Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Dry Age-Related Macular Degeneration Sales by Type (K MT)
Table 27. Global Dry Age-Related Macular Degeneration Market Size by Type (M USD)
Table 28. Global Dry Age-Related Macular Degeneration Sales (K MT) by Type (2020-2025)
Table 29. Global Dry Age-Related Macular Degeneration Sales Market Share by Type (2020-2025)
Table 30. Global Dry Age-Related Macular Degeneration Market Size (M USD) by Type (2020-2025)
Table 31. Global Dry Age-Related Macular Degeneration Market Share by Type (2020-2025)
Table 32. Global Dry Age-Related Macular Degeneration Price (USD/KG) by Type (2020-2025)
Table 33. Global Dry Age-Related Macular Degeneration Sales (K MT) by Application
Table 34. Global Dry Age-Related Macular Degeneration Market Size by Application
Table 35. Global Dry Age-Related Macular Degeneration Sales by Application (2020-2025) & (K MT)
Table 36. Global Dry Age-Related Macular Degeneration Sales Market Share by Application (2020-2025)
Table 37. Global Dry Age-Related Macular Degeneration Market Size by Application (2020-2025) & (M USD)
Table 38. Global Dry Age-Related Macular Degeneration Market Share by Application (2020-2025)
Table 39. Global Dry Age-Related Macular Degeneration Sales Growth Rate by Application (2020-2025)
Table 40. Global Dry Age-Related Macular Degeneration Sales by Region (2020-2025) & (K MT)
Table 41. Global Dry Age-Related Macular Degeneration Sales Market Share by Region (2020-2025)
Table 42. Global Dry Age-Related Macular Degeneration Market Size by Region (2020-2025) & (M USD)
Table 43. Global Dry Age-Related Macular Degeneration Market Size by Region (2020-2025)
Table 44. North America Dry Age-Related Macular Degeneration Sales by Country (2020-2025) & (K MT)
Table 45. North America Dry Age-Related Macular Degeneration Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Dry Age-Related Macular Degeneration Sales by Country (2020-2025) & (K MT)
Table 47. Europe Dry Age-Related Macular Degeneration Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Dry Age-Related Macular Degeneration Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Dry Age-Related Macular Degeneration Market Size by Region (2020-2025) & (M USD)
Table 50. South America Dry Age-Related Macular Degeneration Sales by Country (2020-2025) & (K MT)
Table 51. South America Dry Age-Related Macular Degeneration Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Dry Age-Related Macular Degeneration Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Dry Age-Related Macular Degeneration Market Size by Region (2020-2025) & (M USD)
Table 54. Global Dry Age-Related Macular Degeneration Production (K MT) by Region(2020-2025)
Table 55. Global Dry Age-Related Macular Degeneration Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Dry Age-Related Macular Degeneration Revenue Market Share by Region (2020-2025)
Table 57. Global Dry Age-Related Macular Degeneration Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Dry Age-Related Macular Degeneration Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Dry Age-Related Macular Degeneration Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Dry Age-Related Macular Degeneration Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Dry Age-Related Macular Degeneration Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Santen Pharmaceuticals Basic Information
Table 63. Santen Pharmaceuticals Dry Age-Related Macular Degeneration Product Overview
Table 64. Santen Pharmaceuticals Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Santen Pharmaceuticals Business Overview
Table 66. Santen Pharmaceuticals SWOT Analysis
Table 67. Santen Pharmaceuticals Recent Developments
Table 68. Allergan Basic Information
Table 69. Allergan Dry Age-Related Macular Degeneration Product Overview
Table 70. Allergan Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Allergan Business Overview
Table 72. Allergan SWOT Analysis
Table 73. Allergan Recent Developments
Table 74. Bausch Health Basic Information
Table 75. Bausch Health Dry Age-Related Macular Degeneration Product Overview
Table 76. Bausch Health Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Bausch Health Business Overview
Table 78. Bausch Health SWOT Analysis
Table 79. Bausch Health Recent Developments
Table 80. Alimera Science Basic Information
Table 81. Alimera Science Dry Age-Related Macular Degeneration Product Overview
Table 82. Alimera Science Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Alimera Science Business Overview
Table 84. Alimera Science Recent Developments
Table 85. Phio Pharmaceuticals Basic Information
Table 86. Phio Pharmaceuticals Dry Age-Related Macular Degeneration Product Overview
Table 87. Phio Pharmaceuticals Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Phio Pharmaceuticals Business Overview
Table 89. Phio Pharmaceuticals Recent Developments
Table 90. Ocumension Therapeutics Basic Information
Table 91. Ocumension Therapeutics Dry Age-Related Macular Degeneration Product Overview
Table 92. Ocumension Therapeutics Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Ocumension Therapeutics Business Overview
Table 94. Ocumension Therapeutics Recent Developments
Table 95. Belite Bio Basic Information
Table 96. Belite Bio Dry Age-Related Macular Degeneration Product Overview
Table 97. Belite Bio Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Belite Bio Business Overview
Table 99. Belite Bio Recent Developments
Table 100. Kubota Vision Basic Information
Table 101. Kubota Vision Dry Age-Related Macular Degeneration Product Overview
Table 102. Kubota Vision Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Kubota Vision Business Overview
Table 104. Kubota Vision Recent Developments
Table 105. Iveric Bio Basic Information
Table 106. Iveric Bio Dry Age-Related Macular Degeneration Product Overview
Table 107. Iveric Bio Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Iveric Bio Business Overview
Table 109. Iveric Bio Recent Developments
Table 110. Eyestem Research Basic Information
Table 111. Eyestem Research Dry Age-Related Macular Degeneration Product Overview
Table 112. Eyestem Research Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Eyestem Research Business Overview
Table 114. Eyestem Research Recent Developments
Table 115. Y2 Solution Basic Information
Table 116. Y2 Solution Dry Age-Related Macular Degeneration Product Overview
Table 117. Y2 Solution Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Y2 Solution Business Overview
Table 119. Y2 Solution Recent Developments
Table 120. Stealth Biotherapeutics Basic Information
Table 121. Stealth Biotherapeutics Dry Age-Related Macular Degeneration Product Overview
Table 122. Stealth Biotherapeutics Dry Age-Related Macular Degeneration Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Stealth Biotherapeutics Business Overview
Table 124. Stealth Biotherapeutics Recent Developments
Table 125. Global Dry Age-Related Macular Degeneration Sales Forecast by Region (2026-2035) & (K MT)
Table 126. Global Dry Age-Related Macular Degeneration Market Size Forecast by Region (2026-2035) & (M USD)
Table 127. North America Dry Age-Related Macular Degeneration Sales Forecast by Country (2026-2035) & (K MT)
Table 128. North America Dry Age-Related Macular Degeneration Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Europe Dry Age-Related Macular Degeneration Sales Forecast by Country (2026-2035) & (K MT)
Table 130. Europe Dry Age-Related Macular Degeneration Market Size Forecast by Country (2026-2035) & (M USD)
Table 131. Asia Pacific Dry Age-Related Macular Degeneration Sales Forecast by Region (2026-2035) & (K MT)
Table 132. Asia Pacific Dry Age-Related Macular Degeneration Market Size Forecast by Region (2026-2035) & (M USD)
Table 133. South America Dry Age-Related Macular Degeneration Sales Forecast by Country (2026-2035) & (K MT)
Table 134. South America Dry Age-Related Macular Degeneration Market Size Forecast by Country (2026-2035) & (M USD)
Table 135. Middle East and Africa Dry Age-Related Macular Degeneration Sales Forecast by Country (2026-2035) & (Units)
Table 136. Middle East and Africa Dry Age-Related Macular Degeneration Market Size Forecast by Country (2026-2035) & (M USD)
Table 137. Global Dry Age-Related Macular Degeneration Sales Forecast by Type (2026-2035) & (K MT)
Table 138. Global Dry Age-Related Macular Degeneration Market Size Forecast by Type (2026-2035) & (M USD)
Table 139. Global Dry Age-Related Macular Degeneration Price Forecast by Type (2026-2035) & (USD/KG)
Table 140. Global Dry Age-Related Macular Degeneration Sales (K MT) Forecast by Application (2026-2035)
Table 141. Global Dry Age-Related Macular Degeneration Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Dry Age-Related Macular Degeneration
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Dry Age-Related Macular Degeneration Market Size (M USD), 2025-2035
Figure 5. Global Dry Age-Related Macular Degeneration Market Size (M USD) (2020-2035)
Figure 6. Global Dry Age-Related Macular Degeneration Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Dry Age-Related Macular Degeneration Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Dry Age-Related Macular Degeneration Product Life Cycle
Figure 13. Dry Age-Related Macular Degeneration Sales Share by Manufacturers in 2025
Figure 14. Global Dry Age-Related Macular Degeneration Revenue Share by Manufacturers in 2025
Figure 15. Dry Age-Related Macular Degeneration Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Dry Age-Related Macular Degeneration Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Dry Age-Related Macular Degeneration Revenue in 2025
Figure 18. Industry Chain Map of Dry Age-Related Macular Degeneration
Figure 19. Global Dry Age-Related Macular Degeneration Market PEST Analysis
Figure 20. Global Dry Age-Related Macular Degeneration Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Dry Age-Related Macular Degeneration Market Share by Type
Figure 27. Sales Market Share of Dry Age-Related Macular Degeneration by Type (2020-2025)
Figure 28. Sales Market Share of Dry Age-Related Macular Degeneration by Type in 2025
Figure 29. Market Share of Dry Age-Related Macular Degeneration by Type (2020-2025)
Figure 30. Market Share of Dry Age-Related Macular Degeneration by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Dry Age-Related Macular Degeneration Market Share by Application
Figure 33. Global Dry Age-Related Macular Degeneration Sales Market Share by Application (2020-2025)
Figure 34. Global Dry Age-Related Macular Degeneration Sales Market Share by Application in 2025
Figure 35. Global Dry Age-Related Macular Degeneration Market Share by Application (2020-2025)
Figure 36. Global Dry Age-Related Macular Degeneration Market Share by Application in 2025
Figure 37. Global Dry Age-Related Macular Degeneration Sales Growth Rate by Application (2020-2025)
Figure 38. Global Dry Age-Related Macular Degeneration Sales Market Share by Region (2020-2025)
Figure 39. Global Dry Age-Related Macular Degeneration Market Size by Region (2020-2025)
Figure 40. North America Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Dry Age-Related Macular Degeneration Sales Market Share by Country in 2024
Figure 43. North America Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Dry Age-Related Macular Degeneration Market Size by Country in 2024
Figure 45. U.S. Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Dry Age-Related Macular Degeneration Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Dry Age-Related Macular Degeneration Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Dry Age-Related Macular Degeneration Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Dry Age-Related Macular Degeneration Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Dry Age-Related Macular Degeneration Sales Market Share by Country in 2024
Figure 53. Europe Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Dry Age-Related Macular Degeneration Market Size by Country in 2024
Figure 55. Germany Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Dry Age-Related Macular Degeneration Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Dry Age-Related Macular Degeneration Sales Market Share by Region in 2024
Figure 67. Asia Pacific Dry Age-Related Macular Degeneration Market Size by Region in 2024
Figure 68. China Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Dry Age-Related Macular Degeneration Sales and Growth Rate (K MT)
Figure 79. South America Dry Age-Related Macular Degeneration Sales Market Share by Country in 2024
Figure 80. South America Dry Age-Related Macular Degeneration Market Size and Growth Rate (M USD)
Figure 81. South America Dry Age-Related Macular Degeneration Market Size by Country in 2024
Figure 82. Brazil Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Dry Age-Related Macular Degeneration Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Dry Age-Related Macular Degeneration Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Dry Age-Related Macular Degeneration Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Dry Age-Related Macular Degeneration Market Size by Region in 2024
Figure 92. Saudi Arabia Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Dry Age-Related Macular Degeneration Production Market Share by Region (2020-2025)
Figure 103. North America Dry Age-Related Macular Degeneration Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Dry Age-Related Macular Degeneration Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Dry Age-Related Macular Degeneration Production (K MT) Growth Rate (2020-2025)
Figure 106. China Dry Age-Related Macular Degeneration Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Dry Age-Related Macular Degeneration Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Dry Age-Related Macular Degeneration Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Dry Age-Related Macular Degeneration Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Dry Age-Related Macular Degeneration Market Share Forecast by Type (2026-2035)
Figure 111. Global Dry Age-Related Macular Degeneration Sales Forecast by Application (2026-2035)
Figure 112. Global Dry Age-Related Macular Degeneration Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Dry Age-Related Macular Degeneration
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Dry Age-Related Macular Degeneration Market Size (M USD), 2025-2035
Figure 5. Global Dry Age-Related Macular Degeneration Market Size (M USD) (2020-2035)
Figure 6. Global Dry Age-Related Macular Degeneration Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Dry Age-Related Macular Degeneration Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Dry Age-Related Macular Degeneration Product Life Cycle
Figure 13. Dry Age-Related Macular Degeneration Sales Share by Manufacturers in 2025
Figure 14. Global Dry Age-Related Macular Degeneration Revenue Share by Manufacturers in 2025
Figure 15. Dry Age-Related Macular Degeneration Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Dry Age-Related Macular Degeneration Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Dry Age-Related Macular Degeneration Revenue in 2025
Figure 18. Industry Chain Map of Dry Age-Related Macular Degeneration
Figure 19. Global Dry Age-Related Macular Degeneration Market PEST Analysis
Figure 20. Global Dry Age-Related Macular Degeneration Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Dry Age-Related Macular Degeneration Market Share by Type
Figure 27. Sales Market Share of Dry Age-Related Macular Degeneration by Type (2020-2025)
Figure 28. Sales Market Share of Dry Age-Related Macular Degeneration by Type in 2025
Figure 29. Market Share of Dry Age-Related Macular Degeneration by Type (2020-2025)
Figure 30. Market Share of Dry Age-Related Macular Degeneration by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Dry Age-Related Macular Degeneration Market Share by Application
Figure 33. Global Dry Age-Related Macular Degeneration Sales Market Share by Application (2020-2025)
Figure 34. Global Dry Age-Related Macular Degeneration Sales Market Share by Application in 2025
Figure 35. Global Dry Age-Related Macular Degeneration Market Share by Application (2020-2025)
Figure 36. Global Dry Age-Related Macular Degeneration Market Share by Application in 2025
Figure 37. Global Dry Age-Related Macular Degeneration Sales Growth Rate by Application (2020-2025)
Figure 38. Global Dry Age-Related Macular Degeneration Sales Market Share by Region (2020-2025)
Figure 39. Global Dry Age-Related Macular Degeneration Market Size by Region (2020-2025)
Figure 40. North America Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Dry Age-Related Macular Degeneration Sales Market Share by Country in 2024
Figure 43. North America Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Dry Age-Related Macular Degeneration Market Size by Country in 2024
Figure 45. U.S. Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Dry Age-Related Macular Degeneration Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Dry Age-Related Macular Degeneration Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Dry Age-Related Macular Degeneration Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Dry Age-Related Macular Degeneration Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Dry Age-Related Macular Degeneration Sales Market Share by Country in 2024
Figure 53. Europe Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Dry Age-Related Macular Degeneration Market Size by Country in 2024
Figure 55. Germany Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Dry Age-Related Macular Degeneration Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Dry Age-Related Macular Degeneration Sales Market Share by Region in 2024
Figure 67. Asia Pacific Dry Age-Related Macular Degeneration Market Size by Region in 2024
Figure 68. China Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Dry Age-Related Macular Degeneration Sales and Growth Rate (K MT)
Figure 79. South America Dry Age-Related Macular Degeneration Sales Market Share by Country in 2024
Figure 80. South America Dry Age-Related Macular Degeneration Market Size and Growth Rate (M USD)
Figure 81. South America Dry Age-Related Macular Degeneration Market Size by Country in 2024
Figure 82. Brazil Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Dry Age-Related Macular Degeneration Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Dry Age-Related Macular Degeneration Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Dry Age-Related Macular Degeneration Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Dry Age-Related Macular Degeneration Market Size by Region in 2024
Figure 92. Saudi Arabia Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Dry Age-Related Macular Degeneration Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Dry Age-Related Macular Degeneration Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Dry Age-Related Macular Degeneration Production Market Share by Region (2020-2025)
Figure 103. North America Dry Age-Related Macular Degeneration Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Dry Age-Related Macular Degeneration Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Dry Age-Related Macular Degeneration Production (K MT) Growth Rate (2020-2025)
Figure 106. China Dry Age-Related Macular Degeneration Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Dry Age-Related Macular Degeneration Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Dry Age-Related Macular Degeneration Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Dry Age-Related Macular Degeneration Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Dry Age-Related Macular Degeneration Market Share Forecast by Type (2026-2035)
Figure 111. Global Dry Age-Related Macular Degeneration Sales Forecast by Application (2026-2035)
Figure 112. Global Dry Age-Related Macular Degeneration Market Share Forecast by Application (2026-2035)
